Dihydrogen phosphate salt of a prostaglandin D2 receptor antagonist

Details for Australian Patent Application No. 2006304187 (hide)

Owner Aventis Pharmaceuticals Inc

Inventors Orton, Edward; Langevin, Beverly; Sherer, Daniel

Agent Watermark

Pub. Number AU-B-2006304187

PCT Pub. Number WO2007/047378

Priority 60/726,290 13.10.05 US

Filing date 12 October 2006

Wipo publication date 26 April 2007

Acceptance publication date 28 April 2011

International Classifications

C07D 239/46 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/505 (2006.01) - Pyrimidines

C07D 239/47 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

1 May 2008 PCT application entered the National Phase

  PCT publication WO2007/047378 Priority application(s): WO2007/047378

28 April 2011 Application Accepted

  Published as AU-B-2006304187

25 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006304189-Ultrasonic device for cutting and coagulating

2006304180-Pharmaceutical packaging of an oral dosage combination